本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Conduit Pharmaceuticals Inc.

2.92
+0.12004.29%
盘后2.92-0.0017-0.06%16:50 EDT
成交量:16.43万
成交额:46.95万
市值:278.04万
市盈率:-0.01
高:2.93
开:2.76
低:2.67
收:2.80
数据加载中...
2024/08/16

重要事件披露

Form 8-K - Current report
2024/08/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

重要事件披露

Form 8-K - Current report
2024/07/11

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/07/02

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/17

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/04/16

重要事件披露

Form 8-K - Current report
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/03

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/14

SEC问询函

Form CORRESP - Correspondence
2023/12/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/02

SEC问询函

Form CORRESP - Correspondence
2023/12/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/21

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/11/21

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]